{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:53:41Z","timestamp":1791420821560,"version":"4.3.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,17]]},"DOI":"10.7759\/cureus.84279","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T13:15:09Z","timestamp":1747487709000},"source":"Crossref","is-referenced-by-count":3,"title":["The Role of DNA Methylation in Insulin Resistance and Metabolic Dysregulation in Polycystic Ovary Syndrome Patients: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Lily","family":"Tehrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Tashjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetana","family":"Movva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaacov","family":"Fakiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubov","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz R","year":"2018","unstructured":"Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018, 132:321-36. 10.1097\/AOG.0000000000002698","journal-title":"Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13061113","article-title":"Current guidelines for diagnosing PCOS","volume":"13","author":"Christ JP","year":"2023","unstructured":"Christ JP, Cedars MI. Current guidelines for diagnosing PCOS. Diagnostics (Basel). 2023, 13:1113. 10.3390\/diagnostics13061113","journal-title":"Diagnostics (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14757","article-title":"Challenges in diagnosis and understanding of natural history of polycystic ovary syndrome","volume":"97","author":"Joham AE","year":"2022","unstructured":"Joham AE, Piltonen T, Lujan ME, Kiconco S, Tay CT. Challenges in diagnosis and understanding of natural history of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2022, 97:165-73. 10.1111\/cen.14757","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.04.010","article-title":"Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: A United States population-based study from 2006 to 2019","volume":"229","author":"Yu O","year":"2023","unstructured":"Yu O, Christ JP, Schulze-Rath R, et al.. Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: A United States population-based study from 2006 to 2019. Am J Obstet Gynecol. 2023, 229:39.e1-39.e12. 10.1016\/j.ajog.2023.04.010","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.18.6.0318","article-title":"Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis","volume":"18","author":"Dunaif A","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev. 1997, 18:774-800. 10.1210\/edrv.18.6.0318","journal-title":"Endocr Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido MA","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020, 35:100937. 10.1016\/j.molmet.2020.01.001","journal-title":"Mol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.741764","article-title":"Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome","volume":"12","author":"Ding H","year":"2021","unstructured":"Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, Xie Q. Resistance to the insulin and elevated level of androgen: A major cause of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021, 12:741764. 10.3389\/fendo.2021.741764","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v13.i1.5","article-title":"Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review","volume":"13","author":"Livadas S","year":"2022","unstructured":"Livadas S, Anagnostis P, Bosdou JK, Bantouna D, Paparodis R. Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review. World J Diabetes. 2022, 13:5-26. 10.4239\/wjd.v13.i1.5","journal-title":"World J Diabetes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.46859","article-title":"Type 2 diabetes mellitus in patients with polycystic ovary syndrome","volume":"15","author":"Agrawal A 4th","year":"2023","unstructured":"Agrawal A 4th, Dave A, Jaiswal A. Type 2 diabetes mellitus in patients with polycystic ovary syndrome. Cureus. 2023, 15:e46859. 10.7759\/cureus.46859","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore LD","year":"2013","unstructured":"Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013, 38:23-38. 10.1038\/npp.2012.112","journal-title":"Neuropsychopharmacology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2018.01.002","article-title":"DNA methylation in human diseases","volume":"5","author":"Jin Z","year":"2018","unstructured":"Jin Z, Liu Y. DNA methylation in human diseases. Genes Dis. 2018, 5:1-8. 10.1016\/j.gendis.2018.01.002","journal-title":"Genes Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00352","article-title":"Intrauterine reprogramming of the polycystic ovary syndrome: Evidence from a pilot study of cord blood global methylation analysis","volume":"8","author":"Lambertini L","year":"2017","unstructured":"Lambertini L, Saul SR, Copperman AB, et al.. Intrauterine reprogramming of the polycystic ovary syndrome: Evidence from a pilot study of cord blood global methylation analysis. Front Endocrinol (Lausanne). 2017, 8:352. 10.3389\/fendo.2017.00352","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020302","article-title":"A review on CYP11A1, CYP17A1, and CYP19A1 polymorphism studies: Candidate susceptibility genes for polycystic ovary syndrome (PCOS) and infertility","volume":"13","author":"Heidarzadehpilehrood R","year":"2022","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M, Abdollahzadeh R, Binti Osman M, Sakinah M, Nordin N, Abdul Hamid H. A review on CYP11A1, CYP17A1, and CYP19A1 polymorphism studies: Candidate susceptibility genes for polycystic ovary syndrome (PCOS) and infertility. Genes (Basel). 2022, 13:302. 10.3390\/genes13020302","journal-title":"Genes (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165033","article-title":"Biomarker profiles in women with PCOS and PCOS offspring; A pilot study","volume":"11","author":"Daan NM","year":"2016","unstructured":"Daan NM, Koster MP, de Wilde MA, Dalmeijer GW, Evelein AM, Fauser BC, de Jager W. Biomarker profiles in women with PCOS and PCOS offspring; A pilot study. PLoS One. 2016, 11:e0165033. 10.1371\/journal.pone.0165033","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041500","article-title":"Polycystic ovary syndrome: Challenges and possible solutions","volume":"12","author":"Che Y","year":"2023","unstructured":"Che Y, Yu J, Li YS, Zhu YC, Tao T. Polycystic ovary syndrome: Challenges and possible solutions. J Clin Med. 2023, 12:1500. 10.3390\/jcm12041500","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-22-0027","article-title":"Women with polycystic ovary syndrome have poorer work ability and higher disability retirement rate at midlife: A Northern Finland Birth Cohort 1966 study","volume":"187","author":"Kujanp\u00e4\u00e4 L","year":"2022","unstructured":"Kujanp\u00e4\u00e4 L, Arffman RK, Vaaramo E, et al.. Women with polycystic ovary syndrome have poorer work ability and higher disability retirement rate at midlife: A Northern Finland Birth Cohort 1966 study. Eur J Endocrinol. 2022, 187:479-88. 10.1530\/EJE-22-0027","journal-title":"Eur J Endocrinol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.46658\/JBIMES-24-01","article-title":"Chapter 4: Systematic reviews of effectiveness","author":"Aromataris E","year":"2024","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z. Chapter 4: Systematic reviews of effectiveness. JBI Manual for Evidence Synthesis. Aromataris E, Munn Z (ed): JBI, Adelaide, Australia; 2024. 10.46658\/JBIMES-24-01"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011458","article-title":"Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)","volume":"6","author":"Downes MJ","year":"2016","unstructured":"Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016, 6:e011458. 10.1136\/bmjopen-2016-011458","journal-title":"BMJ Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3233\/THC-218002","article-title":"DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of polycystic ovary syndrome (PCOS)","volume":"29","author":"Zhong X","year":"2021","unstructured":"Zhong X, Jin F, Huang C, Du M, Gao M, Wei X. DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of polycystic ovary syndrome (PCOS). Technol Health Care. 2021, 29:11-25. 10.3233\/THC-218002","journal-title":"Technol Health Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-013-9602-z","article-title":"The relationship between insulin resistance and CpG island methylation of LMNA gene in polycystic ovary syndrome","volume":"67","author":"Ting W","year":"2013","unstructured":"Ting W, Yanyan Q, Jian H, Keqin H, Duan M. The relationship between insulin resistance and CpG island methylation of LMNA gene in polycystic ovary syndrome. Cell Biochem Biophys. 2013, 67:1041-7. 10.1007\/s12013-013-9602-z","journal-title":"Cell Biochem Biophys"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.664843","article-title":"Characterization of DNA methylation and screening of epigenetic markers in polycystic ovary syndrome","volume":"9","author":"Cao P","year":"2021","unstructured":"Cao P, Yang W, Wang P, Li X, Nashun B. Characterization of DNA methylation and screening of epigenetic markers in polycystic ovary syndrome. Front Cell Dev Biol. 2021, 9:664843. 10.3389\/fcell.2021.664843","journal-title":"Front Cell Dev Biol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2024.149165","article-title":"The regulatory interplay between miRNA and DNA methylation orchestrates vital ovarian functions and associated traits in PCOS","volume":"940","author":"Bhingardeve S","year":"2025","unstructured":"Bhingardeve S, Sagvekar P, Desai S, Mangoli V, Jagtap R, Mukherjee S. The regulatory interplay between miRNA and DNA methylation orchestrates vital ovarian functions and associated traits in PCOS. Gene. 2025, 940:149165. 10.1016\/j.gene.2024.149165","journal-title":"Gene"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00935","article-title":"Transcriptional and epigenetic changes influencing skeletal muscle metabolism in women with polycystic ovary syndrome","volume":"103","author":"Nilsson E","year":"2018","unstructured":"Nilsson E, Benrick A, Kokosar M, et al.. Transcriptional and epigenetic changes influencing skeletal muscle metabolism in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2018, 103:4465-77. 10.1210\/jc.2018-00935","journal-title":"J Clin Endocrinol Metab"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.10.039","article-title":"Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: The impact of the leukocyte methylation of PPARGC1A promoter","volume":"107","author":"Zhao H","year":"2017","unstructured":"Zhao H, Zhao Y, Ren Y, et al.. Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: The impact of the leukocyte methylation of PPARGC1A promoter. Fertil Steril. 2017, 107:467-474.e5. 10.1016\/j.fertnstert.2016.10.039","journal-title":"Fertil Steril"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005455","article-title":"Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity","volume":"11","author":"Jones MR","year":"2015","unstructured":"Jones MR, Brower MA, Xu N, et al.. Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity. PLoS Genet. 2015, 11:e1005455. 10.1371\/journal.pgen.1005455","journal-title":"PLoS Genet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-06210-3","article-title":"Association between single nucleotide polymorphisms, TGF-\u03b21 promoter methylation, and polycystic ovary syndrome","volume":"24","author":"Gao M","year":"2024","unstructured":"Gao M, Liu X, Gu H, Xu H, Zhong W, Wei X, Zhong X. Association between single nucleotide polymorphisms, TGF-\u03b21 promoter methylation, and polycystic ovary syndrome. BMC Pregnancy Childbirth. 2024, 24:5. 10.1186\/s12884-023-06210-3","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064801","article-title":"Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome","volume":"8","author":"Shen HR","year":"2013","unstructured":"Shen HR, Qiu LH, Zhang ZQ, Qin YY, Cao C, Di W. Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome. PLoS One. 2013, 8:e64801. 10.1371\/journal.pone.0064801","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2024.2305082","article-title":"Resistance and aerobic training increases genome-wide DNA methylation in women with polycystic ovary syndrome","volume":"19","author":"Miranda Furtado CL","year":"2024","unstructured":"Miranda Furtado CL, Hansen M, Kogure GS, et al.. Resistance and aerobic training increases genome-wide DNA methylation in women with polycystic ovary syndrome. Epigenetics. 2024, 19:2305082. 10.1080\/15592294.2024.2305082","journal-title":"Epigenetics"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1994.266.2.C319","article-title":"The insulin receptor: Structure, function, and signaling","volume":"266","author":"Lee J","year":"1994","unstructured":"Lee J, Pilch PF. The insulin receptor: Structure, function, and signaling. Am J Physiol. 1994, 266:C319-34. 10.1152\/ajpcell.1994.266.2.C319","journal-title":"Am J Physiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123688","article-title":"Lamin A\/C: Function in normal and tumor cells","volume":"12","author":"Dubik N","year":"2020","unstructured":"Dubik N, Mai S. Lamin A\/C: Function in normal and tumor cells. Cancers (Basel). 2020, 12:3688. 10.3390\/cancers12123688","journal-title":"Cancers (Basel)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1152\/advan.00052.2006","article-title":"PGC-1alpha: A key regulator of energy metabolism","volume":"30","author":"Liang H","year":"2006","unstructured":"Liang H, Ward WF. PGC-1alpha: A key regulator of energy metabolism. Adv Physiol Educ. 2006, 30:145-51. 10.1152\/advan.00052.2006","journal-title":"Adv Physiol Educ"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/1933719113485294","article-title":"The role of TGF-\u03b2 in polycystic ovary syndrome","volume":"21","author":"Raja-Khan N","year":"2014","unstructured":"Raja-Khan N, Urbanek M, Rodgers RJ, Legro RS. The role of TGF-\u03b2 in polycystic ovary syndrome. Reprod Sci. 2014, 21:20-31. 10.1177\/1933719113485294","journal-title":"Reprod Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/358847-the-role-of-dna-methylation-in-insulin-resistance-and-metabolic-dysregulation-in-polycystic-ovary-syndrome-patients-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T13:15:09Z","timestamp":1747487709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/358847-the-role-of-dna-methylation-in-insulin-resistance-and-metabolic-dysregulation-in-polycystic-ovary-syndrome-patients-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.84279","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,17]]}}}